Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the MRI Contrast Media Market During the Forecast Period, and Why?

The market size for MRI contrast media has seen a substantial growth in recent times. Its worth which is expected to increase from $1.56 billion in 2024 to $1.66 billion in 2025 signifies a compound annual growth rate (CAGR) of 6.4%. Factors contributing to its growth over the historic period include the surging demand for early diagnosis, augmentation of diagnostic accuracy and patient outcomes, heightened public awareness, the evolution of combined imaging modalities, and the discovery of new applications for contrast agents.

Anticipations are high for robust expansion in the MRI contrast media market in the near future. It is predicted to swell to a size of $2.11 billion by 2029, maintaining a compound annual growth rate (CAGR) of 6.1%. The escalation foreseen in this period is credited to the increment in cancer cases, surging incidence of chronic illnesses, growth in research and development expenditure and activities, soaring healthcare costs and widening applications of MRI. Key trends propelling this projection period consist of advancements through collaborative research, technological evolution, product innovation, creation of safer and more effective contrast agents, as well as product revolutions fueled by pharmaceutical and biotech firms.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the MRI Contrast Media Market?

The MRI contrast media market is anticipated to expand due to an increase in the incidences of cancer. This upward trend in cancer rates is attributed to different factors ranging from demographic and lifestyle to environmental, genetic, and healthcare-related aspects. The use of gadolinium-based contrast agents during MRI procedures enhances image clarity by modifying tissue magnetic properties, thus assisting in identifying, measuring, assessing tumor invasion into nearby tissues. A report issued by the World Health Organization (WHO) in February 2024 showed an estimated 20 million new cancer cases globally in 2022, resulting in about 9.7 million fatalities. The report forecasted a notable climb in cancer cases by 2050, predicting over 35 million new cases, symbolizing a 77% surge from the 20 million cases in 2022. As such, the escalating number of cancer cases is fueling the growth of the MRI contrast media market.

Request Your Free MRI Contrast Media Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=14964&type=smp

Which Companies Are Poised to Shape the Future of the MRI Contrast Media Market?

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

What Are the Latest Innovations and Trends Influencing the MRI Contrast Media Market?

Leading businesses in the MRI contrast media industry are channeling their efforts towards the creation and distribution of state-of-the-art products, such as macrocyclic gadolinium-based contrast agents (GBCA). These advanced solutions are designed to boost the accuracy and safety aspects of MRI scans. Macrocyclic gadolinium-based contrast agents (GBCA) serve as essential contrast materials used in medical imaging, particularly magnetic resonance imaging. For example, in February 2023, Guerbet, a French company specializing in MRI contrast media, introduced the Elucirem (gadopiclenol) injection. The gadopiclenol injection’s uniqueness is derived from its highly stable macrocyclic gadolinium-based contrast agent (GBCA) that possesses unrivaled relaxivity within its category for MRI. The innovative composition of gadopiclenol is especially significant due to its proficient detection and display of lesions with irregular vascularity across different areas of the central nervous system (including the brain, spinal cord and associated tissues), and the body which includes head, neck, thoracic cavity, abdomen, pelvis, and the musculoskeletal system.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/mri-contrast-media-global-market-report

Which Segments of the MRI Contrast Media Market Hold the Most Potential for Future Development?

The mri contrast media market covered in this report is segmented –

1) By Product: Extracellular Contrast Agents, Blood-Pool Agent, Hepatobiliary Agents

2) By Application: Neurological Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Cancer Detection, Other Applications

3) By End-User: Hospitals, Diagnostic And Imaging Centers, Research Institutes, Other End Users

Subsegments:

1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA), Non-Gadolinium-Based Contrast Agents

2) By Blood-Pool Agent: Macromolecular Agents, Nanoparticle-Based Agents

3) By Hepatobiliary Agents: Hepatocyte-Specific Agents, Biliary-Specific Agents

What Regions Are Contributing Significantly to the Growth of the MRI Contrast Media Market?

North America was the largest region in the MRI contrast media market in 2024. The regions covered in the MRI contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the MRI Contrast Media Market Defined?

MRI contrast media refer to substances used in magnetic resonance imaging (MRI) to enhance the visibility of internal body structures. These contrast agents work by altering the magnetic properties of tissues, thereby improving the contrast in the resulting images.

Browse Through More Similar Reports By The Business Research Company:

Media Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/media-global-market-report

Print Media Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/print-media-global-market-report

Contrast Enhanced Ultrasound Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: